ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceuticals Contract Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-32O17656
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceuticals Contract Testing Service Market Research Report 2024
BUY CHAPTERS

Global Pharmaceuticals Contract Testing Service Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-32O17656
Report
October 2025
Pages:164
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS Ltd
Boston Analytical
DYNALABS
ADPEN Laboratories
ARL Bio Pharma
West Pharmaceutical
Microbac
Element (Analytical Lab Group)
Piramal Pharma Solutions
CTI
Weipu
PONY Medicine

Pharmaceuticals Contract Testing Service Market

The global Pharmaceuticals Contract Testing Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, CRO accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceuticals Contract Testing Service leading manufacturers including Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceuticals Contract Testing Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmaceuticals Contract Testing Service Market Report

Report Metric Details
Report Name Pharmaceuticals Contract Testing Service Market
Segment by Type
  • Raw Material Testing
  • Microbiological Testing
  • Drug Packaging Material Testing
  • Biological Analysis and Testing
  • Other
Segment by Application
  • CRO
  • CMO and CDMO
  • Finished Drugs and Environment
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Piramal Pharma Solutions, CTI, Weipu, PONY Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmaceuticals Contract Testing Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceuticals Contract Testing Service Market report?

Ans: The main players in the Pharmaceuticals Contract Testing Service Market are Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, LabCorp (Covance), PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical, DYNALABS, ADPEN Laboratories, ARL Bio Pharma, West Pharmaceutical, Microbac, Element (Analytical Lab Group), Piramal Pharma Solutions, CTI, Weipu, PONY Medicine

What are the Application segmentation covered in the Pharmaceuticals Contract Testing Service Market report?

Ans: The Applications covered in the Pharmaceuticals Contract Testing Service Market report are CRO, CMO and CDMO, Finished Drugs and Environment

What are the Type segmentation covered in the Pharmaceuticals Contract Testing Service Market report?

Ans: The Types covered in the Pharmaceuticals Contract Testing Service Market report are Raw Material Testing, Microbiological Testing, Drug Packaging Material Testing, Biological Analysis and Testing, Other

1 Study Coverage
1.1 Introduction to Pharmaceuticals Contract Testing Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceuticals Contract Testing Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Raw Material Testing
1.2.3 Microbiological Testing
1.2.4 Drug Packaging Material Testing
1.2.5 Biological Analysis and Testing
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceuticals Contract Testing Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 CRO
1.3.3 CMO and CDMO
1.3.4 Finished Drugs and Environment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceuticals Contract Testing Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceuticals Contract Testing Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceuticals Contract Testing Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceuticals Contract Testing Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Raw Material Testing Market Size by Players
3.3.2 Microbiological Testing Market Size by Players
3.3.3 Drug Packaging Material Testing Market Size by Players
3.3.4 Biological Analysis and Testing Market Size by Players
3.3.5 Other Market Size by Players
3.4 Global Pharmaceuticals Contract Testing Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceuticals Contract Testing Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceuticals Contract Testing Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceuticals Contract Testing Service Market Size by Type (2020-2031)
6.4 North America Pharmaceuticals Contract Testing Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceuticals Contract Testing Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceuticals Contract Testing Service Market Size by Type (2020-2031)
7.4 Europe Pharmaceuticals Contract Testing Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceuticals Contract Testing Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceuticals Contract Testing Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceuticals Contract Testing Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceuticals Contract Testing Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceuticals Contract Testing Service Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceuticals Contract Testing Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceuticals Contract Testing Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceuticals Contract Testing Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceuticals Contract Testing Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceuticals Contract Testing Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins
11.1.1 Eurofins Corporation Information
11.1.2 Eurofins Business Overview
11.1.3 Eurofins Pharmaceuticals Contract Testing Service Product Features and Attributes
11.1.4 Eurofins Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Pharmaceuticals Contract Testing Service Revenue by Product in 2024
11.1.6 Eurofins Pharmaceuticals Contract Testing Service Revenue by Application in 2024
11.1.7 Eurofins Pharmaceuticals Contract Testing Service Revenue by Geographic Area in 2024
11.1.8 Eurofins Pharmaceuticals Contract Testing Service SWOT Analysis
11.1.9 Eurofins Recent Developments
11.2 WuXi AppTec
11.2.1 WuXi AppTec Corporation Information
11.2.2 WuXi AppTec Business Overview
11.2.3 WuXi AppTec Pharmaceuticals Contract Testing Service Product Features and Attributes
11.2.4 WuXi AppTec Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.2.5 WuXi AppTec Pharmaceuticals Contract Testing Service Revenue by Product in 2024
11.2.6 WuXi AppTec Pharmaceuticals Contract Testing Service Revenue by Application in 2024
11.2.7 WuXi AppTec Pharmaceuticals Contract Testing Service Revenue by Geographic Area in 2024
11.2.8 WuXi AppTec Pharmaceuticals Contract Testing Service SWOT Analysis
11.2.9 WuXi AppTec Recent Developments
11.3 Pace Analytical Services
11.3.1 Pace Analytical Services Corporation Information
11.3.2 Pace Analytical Services Business Overview
11.3.3 Pace Analytical Services Pharmaceuticals Contract Testing Service Product Features and Attributes
11.3.4 Pace Analytical Services Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.3.5 Pace Analytical Services Pharmaceuticals Contract Testing Service Revenue by Product in 2024
11.3.6 Pace Analytical Services Pharmaceuticals Contract Testing Service Revenue by Application in 2024
11.3.7 Pace Analytical Services Pharmaceuticals Contract Testing Service Revenue by Geographic Area in 2024
11.3.8 Pace Analytical Services Pharmaceuticals Contract Testing Service SWOT Analysis
11.3.9 Pace Analytical Services Recent Developments
11.4 Catalent
11.4.1 Catalent Corporation Information
11.4.2 Catalent Business Overview
11.4.3 Catalent Pharmaceuticals Contract Testing Service Product Features and Attributes
11.4.4 Catalent Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.4.5 Catalent Pharmaceuticals Contract Testing Service Revenue by Product in 2024
11.4.6 Catalent Pharmaceuticals Contract Testing Service Revenue by Application in 2024
11.4.7 Catalent Pharmaceuticals Contract Testing Service Revenue by Geographic Area in 2024
11.4.8 Catalent Pharmaceuticals Contract Testing Service SWOT Analysis
11.4.9 Catalent Recent Developments
11.5 LabCorp (Covance)
11.5.1 LabCorp (Covance) Corporation Information
11.5.2 LabCorp (Covance) Business Overview
11.5.3 LabCorp (Covance) Pharmaceuticals Contract Testing Service Product Features and Attributes
11.5.4 LabCorp (Covance) Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.5.5 LabCorp (Covance) Pharmaceuticals Contract Testing Service Revenue by Product in 2024
11.5.6 LabCorp (Covance) Pharmaceuticals Contract Testing Service Revenue by Application in 2024
11.5.7 LabCorp (Covance) Pharmaceuticals Contract Testing Service Revenue by Geographic Area in 2024
11.5.8 LabCorp (Covance) Pharmaceuticals Contract Testing Service SWOT Analysis
11.5.9 LabCorp (Covance) Recent Developments
11.6 PPD
11.6.1 PPD Corporation Information
11.6.2 PPD Business Overview
11.6.3 PPD Pharmaceuticals Contract Testing Service Product Features and Attributes
11.6.4 PPD Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.6.5 PPD Recent Developments
11.7 Element (Exova)
11.7.1 Element (Exova) Corporation Information
11.7.2 Element (Exova) Business Overview
11.7.3 Element (Exova) Pharmaceuticals Contract Testing Service Product Features and Attributes
11.7.4 Element (Exova) Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.7.5 Element (Exova) Recent Developments
11.8 ALS Pharmaceutical
11.8.1 ALS Pharmaceutical Corporation Information
11.8.2 ALS Pharmaceutical Business Overview
11.8.3 ALS Pharmaceutical Pharmaceuticals Contract Testing Service Product Features and Attributes
11.8.4 ALS Pharmaceutical Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.8.5 ALS Pharmaceutical Recent Developments
11.9 Intertek Group
11.9.1 Intertek Group Corporation Information
11.9.2 Intertek Group Business Overview
11.9.3 Intertek Group Pharmaceuticals Contract Testing Service Product Features and Attributes
11.9.4 Intertek Group Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.9.5 Intertek Group Recent Developments
11.10 SGS
11.10.1 SGS Corporation Information
11.10.2 SGS Business Overview
11.10.3 SGS Pharmaceuticals Contract Testing Service Product Features and Attributes
11.10.4 SGS Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Boston Analytical
11.11.1 Boston Analytical Corporation Information
11.11.2 Boston Analytical Business Overview
11.11.3 Boston Analytical Pharmaceuticals Contract Testing Service Product Features and Attributes
11.11.4 Boston Analytical Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.11.5 Boston Analytical Recent Developments
11.12 DYNALABS
11.12.1 DYNALABS Corporation Information
11.12.2 DYNALABS Business Overview
11.12.3 DYNALABS Pharmaceuticals Contract Testing Service Product Features and Attributes
11.12.4 DYNALABS Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.12.5 DYNALABS Recent Developments
11.13 ADPEN Laboratories
11.13.1 ADPEN Laboratories Corporation Information
11.13.2 ADPEN Laboratories Business Overview
11.13.3 ADPEN Laboratories Pharmaceuticals Contract Testing Service Product Features and Attributes
11.13.4 ADPEN Laboratories Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.13.5 ADPEN Laboratories Recent Developments
11.14 ARL Bio Pharma
11.14.1 ARL Bio Pharma Corporation Information
11.14.2 ARL Bio Pharma Business Overview
11.14.3 ARL Bio Pharma Pharmaceuticals Contract Testing Service Product Features and Attributes
11.14.4 ARL Bio Pharma Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.14.5 ARL Bio Pharma Recent Developments
11.15 West Pharmaceutical
11.15.1 West Pharmaceutical Corporation Information
11.15.2 West Pharmaceutical Business Overview
11.15.3 West Pharmaceutical Pharmaceuticals Contract Testing Service Product Features and Attributes
11.15.4 West Pharmaceutical Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.15.5 West Pharmaceutical Recent Developments
11.16 Microbac
11.16.1 Microbac Corporation Information
11.16.2 Microbac Business Overview
11.16.3 Microbac Pharmaceuticals Contract Testing Service Product Features and Attributes
11.16.4 Microbac Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.16.5 Microbac Recent Developments
11.17 Element (Analytical Lab Group)
11.17.1 Element (Analytical Lab Group) Corporation Information
11.17.2 Element (Analytical Lab Group) Business Overview
11.17.3 Element (Analytical Lab Group) Pharmaceuticals Contract Testing Service Product Features and Attributes
11.17.4 Element (Analytical Lab Group) Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.17.5 Element (Analytical Lab Group) Recent Developments
11.18 Piramal Pharma Solutions
11.18.1 Piramal Pharma Solutions Corporation Information
11.18.2 Piramal Pharma Solutions Business Overview
11.18.3 Piramal Pharma Solutions Pharmaceuticals Contract Testing Service Product Features and Attributes
11.18.4 Piramal Pharma Solutions Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.18.5 Piramal Pharma Solutions Recent Developments
11.19 CTI
11.19.1 CTI Corporation Information
11.19.2 CTI Business Overview
11.19.3 CTI Pharmaceuticals Contract Testing Service Product Features and Attributes
11.19.4 CTI Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.19.5 CTI Recent Developments
11.20 Weipu
11.20.1 Weipu Corporation Information
11.20.2 Weipu Business Overview
11.20.3 Weipu Pharmaceuticals Contract Testing Service Product Features and Attributes
11.20.4 Weipu Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.20.5 Weipu Recent Developments
11.21 PONY Medicine
11.21.1 PONY Medicine Corporation Information
11.21.2 PONY Medicine Business Overview
11.21.3 PONY Medicine Pharmaceuticals Contract Testing Service Product Features and Attributes
11.21.4 PONY Medicine Pharmaceuticals Contract Testing Service Revenue and Gross Margin (2020-2025)
11.21.5 PONY Medicine Recent Developments
12 Pharmaceuticals Contract Testing ServiceIndustry Chain Analysis
12.1 Pharmaceuticals Contract Testing Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceuticals Contract Testing Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceuticals Contract Testing Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS Ltd
Boston Analytical
DYNALABS
ADPEN Laboratories
ARL Bio Pharma
West Pharmaceutical
Microbac
Element (Analytical Lab Group)
Piramal Pharma Solutions
CTI
Weipu
PONY Medicine
List of Tables
 Table 1. Global Pharmaceuticals Contract Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmaceuticals Contract Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmaceuticals Contract Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmaceuticals Contract Testing Service Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmaceuticals Contract Testing Service Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Pharmaceuticals Contract Testing Service Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Pharmaceuticals Contract Testing Service Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Pharmaceuticals Contract Testing Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals Contract Testing Service as of 2024)
 Table 11. Global Pharmaceuticals Contract Testing Service Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Pharmaceuticals Contract Testing Service Companies Headquarters
 Table 13. Global Pharmaceuticals Contract Testing Service Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Pharmaceuticals Contract Testing Service Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Pharmaceuticals Contract Testing Service Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Pharmaceuticals Contract Testing Service Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Pharmaceuticals Contract Testing Service Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Pharmaceuticals Contract Testing Service High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Pharmaceuticals Contract Testing Service Growth Accelerators and Market Barriers
 Table 25. North America Pharmaceuticals Contract Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Pharmaceuticals Contract Testing Service Growth Accelerators and Market Barriers
 Table 27. Europe Pharmaceuticals Contract Testing Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Pharmaceuticals Contract Testing Service Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Pharmaceuticals Contract Testing Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Pharmaceuticals Contract Testing Service Investment Opportunities and Key Challenges
 Table 31. Central and South America Pharmaceuticals Contract Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Pharmaceuticals Contract Testing Service Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Pharmaceuticals Contract Testing Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Eurofins Corporation Information
 Table 35. Eurofins Description and Major Businesses
 Table 36. Eurofins Product Features and Attributes
 Table 37. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Eurofins Revenue Proportion by Product in 2024
 Table 39. Eurofins Revenue Proportion by Application in 2024
 Table 40. Eurofins Revenue Proportion by Geographic Area in 2024
 Table 41. Eurofins Pharmaceuticals Contract Testing Service SWOT Analysis
 Table 42. Eurofins Recent Developments
 Table 43. WuXi AppTec Corporation Information
 Table 44. WuXi AppTec Description and Major Businesses
 Table 45. WuXi AppTec Product Features and Attributes
 Table 46. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. WuXi AppTec Revenue Proportion by Product in 2024
 Table 48. WuXi AppTec Revenue Proportion by Application in 2024
 Table 49. WuXi AppTec Revenue Proportion by Geographic Area in 2024
 Table 50. WuXi AppTec Pharmaceuticals Contract Testing Service SWOT Analysis
 Table 51. WuXi AppTec Recent Developments
 Table 52. Pace Analytical Services Corporation Information
 Table 53. Pace Analytical Services Description and Major Businesses
 Table 54. Pace Analytical Services Product Features and Attributes
 Table 55. Pace Analytical Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Pace Analytical Services Revenue Proportion by Product in 2024
 Table 57. Pace Analytical Services Revenue Proportion by Application in 2024
 Table 58. Pace Analytical Services Revenue Proportion by Geographic Area in 2024
 Table 59. Pace Analytical Services Pharmaceuticals Contract Testing Service SWOT Analysis
 Table 60. Pace Analytical Services Recent Developments
 Table 61. Catalent Corporation Information
 Table 62. Catalent Description and Major Businesses
 Table 63. Catalent Product Features and Attributes
 Table 64. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Catalent Revenue Proportion by Product in 2024
 Table 66. Catalent Revenue Proportion by Application in 2024
 Table 67. Catalent Revenue Proportion by Geographic Area in 2024
 Table 68. Catalent Pharmaceuticals Contract Testing Service SWOT Analysis
 Table 69. Catalent Recent Developments
 Table 70. LabCorp (Covance) Corporation Information
 Table 71. LabCorp (Covance) Description and Major Businesses
 Table 72. LabCorp (Covance) Product Features and Attributes
 Table 73. LabCorp (Covance) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. LabCorp (Covance) Revenue Proportion by Product in 2024
 Table 75. LabCorp (Covance) Revenue Proportion by Application in 2024
 Table 76. LabCorp (Covance) Revenue Proportion by Geographic Area in 2024
 Table 77. LabCorp (Covance) Pharmaceuticals Contract Testing Service SWOT Analysis
 Table 78. LabCorp (Covance) Recent Developments
 Table 79. PPD Corporation Information
 Table 80. PPD Description and Major Businesses
 Table 81. PPD Product Features and Attributes
 Table 82. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. PPD Recent Developments
 Table 84. Element (Exova) Corporation Information
 Table 85. Element (Exova) Description and Major Businesses
 Table 86. Element (Exova) Product Features and Attributes
 Table 87. Element (Exova) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Element (Exova) Recent Developments
 Table 89. ALS Pharmaceutical Corporation Information
 Table 90. ALS Pharmaceutical Description and Major Businesses
 Table 91. ALS Pharmaceutical Product Features and Attributes
 Table 92. ALS Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. ALS Pharmaceutical Recent Developments
 Table 94. Intertek Group Corporation Information
 Table 95. Intertek Group Description and Major Businesses
 Table 96. Intertek Group Product Features and Attributes
 Table 97. Intertek Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Intertek Group Recent Developments
 Table 99. SGS Corporation Information
 Table 100. SGS Description and Major Businesses
 Table 101. SGS Product Features and Attributes
 Table 102. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. SGS Recent Developments
 Table 104. Boston Analytical Corporation Information
 Table 105. Boston Analytical Description and Major Businesses
 Table 106. Boston Analytical Product Features and Attributes
 Table 107. Boston Analytical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Boston Analytical Recent Developments
 Table 109. DYNALABS Corporation Information
 Table 110. DYNALABS Description and Major Businesses
 Table 111. DYNALABS Product Features and Attributes
 Table 112. DYNALABS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. DYNALABS Recent Developments
 Table 114. ADPEN Laboratories Corporation Information
 Table 115. ADPEN Laboratories Description and Major Businesses
 Table 116. ADPEN Laboratories Product Features and Attributes
 Table 117. ADPEN Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. ADPEN Laboratories Recent Developments
 Table 119. ARL Bio Pharma Corporation Information
 Table 120. ARL Bio Pharma Description and Major Businesses
 Table 121. ARL Bio Pharma Product Features and Attributes
 Table 122. ARL Bio Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. ARL Bio Pharma Recent Developments
 Table 124. West Pharmaceutical Corporation Information
 Table 125. West Pharmaceutical Description and Major Businesses
 Table 126. West Pharmaceutical Product Features and Attributes
 Table 127. West Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. West Pharmaceutical Recent Developments
 Table 129. Microbac Corporation Information
 Table 130. Microbac Description and Major Businesses
 Table 131. Microbac Product Features and Attributes
 Table 132. Microbac Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Microbac Recent Developments
 Table 134. Element (Analytical Lab Group) Corporation Information
 Table 135. Element (Analytical Lab Group) Description and Major Businesses
 Table 136. Element (Analytical Lab Group) Product Features and Attributes
 Table 137. Element (Analytical Lab Group) Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Element (Analytical Lab Group) Recent Developments
 Table 139. Piramal Pharma Solutions Corporation Information
 Table 140. Piramal Pharma Solutions Description and Major Businesses
 Table 141. Piramal Pharma Solutions Product Features and Attributes
 Table 142. Piramal Pharma Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Piramal Pharma Solutions Recent Developments
 Table 144. CTI Corporation Information
 Table 145. CTI Description and Major Businesses
 Table 146. CTI Product Features and Attributes
 Table 147. CTI Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. CTI Recent Developments
 Table 149. Weipu Corporation Information
 Table 150. Weipu Description and Major Businesses
 Table 151. Weipu Product Features and Attributes
 Table 152. Weipu Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Weipu Recent Developments
 Table 154. PONY Medicine Corporation Information
 Table 155. PONY Medicine Description and Major Businesses
 Table 156. PONY Medicine Product Features and Attributes
 Table 157. PONY Medicine Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. PONY Medicine Recent Developments
 Table 159. Raw Materials Key Suppliers
 Table 160. Distributors List
 Table 161. Market Trends and Market Evolution
 Table 162. Market Drivers and Opportunities
 Table 163. Market Challenges, Risks, and Restraints
 Table 164. Research Programs/Design for This Report
 Table 165. Key Data Information from Secondary Sources
 Table 166. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceuticals Contract Testing Service Product Picture
 Figure 2. Global Pharmaceuticals Contract Testing Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Raw Material Testing Product Picture
 Figure 4. Microbiological Testing Product Picture
 Figure 5. Drug Packaging Material Testing Product Picture
 Figure 6. Biological Analysis and Testing Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Pharmaceuticals Contract Testing Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. CRO
 Figure 10. CMO and CDMO
 Figure 11. Finished Drugs and Environment
 Figure 12. Pharmaceuticals Contract Testing Service Report Years Considered
 Figure 13. Global Pharmaceuticals Contract Testing Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Pharmaceuticals Contract Testing Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Pharmaceuticals Contract Testing Service Revenue Market Share by Region (2020-2031)
 Figure 17. Global Pharmaceuticals Contract Testing Service Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Raw Material Testing Revenue Market Share by Player in 2024
 Figure 20. Microbiological Testing Revenue Market Share by Player in 2024
 Figure 21. Drug Packaging Material Testing Revenue Market Share by Player in 2024
 Figure 22. Biological Analysis and Testing Revenue Market Share by Player in 2024
 Figure 23. Other Revenue Market Share by Player in 2024
 Figure 24. Global Pharmaceuticals Contract Testing Service Revenue Market Share by Type (2020-2031)
 Figure 25. Global Pharmaceuticals Contract Testing Service Revenue Market Share by Application (2020-2031)
 Figure 26. North America Pharmaceuticals Contract Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Pharmaceuticals Contract Testing Service Revenue (US$ Million) in 2024
 Figure 28. North America Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Pharmaceuticals Contract Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Pharmaceuticals Contract Testing Service Revenue (US$ Million) in 2024
 Figure 35. Europe Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 38. France Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Pharmaceuticals Contract Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Pharmaceuticals Contract Testing Service Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 50. India Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Pharmaceuticals Contract Testing Service Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Pharmaceuticals Contract Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Pharmaceuticals Contract Testing Service Revenue (US$ Million) in 2024
 Figure 58. Central and South America Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Pharmaceuticals Contract Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Pharmaceuticals Contract Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Pharmaceuticals Contract Testing Service Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Pharmaceuticals Contract Testing Service Revenue (US$ Million) in 2024
 Figure 64. South America Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Pharmaceuticals Contract Testing Service Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Pharmaceuticals Contract Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Pharmaceuticals Contract Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Pharmaceuticals Contract Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Pharmaceuticals Contract Testing Service Revenue (2020-2025) & (US$ Million)
 Figure 70. Pharmaceuticals Contract Testing Service Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions